
Kamika 250mg Injection
Marketer
Kanraxy Pharma
Salt Composition
Amikacin (250mg)
Overview Kamika 250mg Injection
The antibiotic injection, Kamika 250mg, combats a broad spectrum of bacterial infections, encompassing urinary tract, bone, joint, lung (pneumonia), brain, and bloodstream infections, among others. Prophylactically, it's administered to hospitalized patients to avert infections. Its mechanism involves inhibiting bacterial proliferation. Administered intravenously (drip) or via intramuscular/intravenous injection by a healthcare professional only, self-administration is strictly prohibited. Consistent usage, adhering to the prescribed dosage intervals, is crucial. Complete the entire course, regardless of symptom improvement; premature cessation risks relapse or infection exacerbation. Common adverse effects include injection site reactions and elevated blood urea nitrogen. Persistent side effects or treatment inefficacy warrant immediate medical consultation. High dosages may induce ataxia (loss of balance), nephropathy (kidney damage), and hearing impairment. Strict adherence to the physician's instructions is paramount, potentially involving regular kidney function, hearing, and urine assessments. Pregnancy contraindicates its use; inform your doctor about pregnancy, pregnancy plans, or breastfeeding.
Uses of Kamika 250mg Injection
Infections caused by bacteria
Major Benefits of Kamika 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Kamika 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Kamika 250mg Injection:
Administering this medication will be handled by your physician or their associate; self-medication is strictly prohibited.
How Kamika 250mg Injection works:
Kamika 250mg injection is a bacterial growth inhibitor, acting as an antibiotic by blocking the production of vital bacterial proteins.
SAFETY ADVICE
AlcoholSAFE
There are no reported adverse reactions from concurrent use of Kamika 250mg Injection and alcohol.
PregnancyCONSULT YOUR DOCTOR
Administering Kamika 250mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. Exceptions may be made in critical circumstances where a physician deems the potential benefits outweigh the inherent dangers. Always seek medical advice before use.
Breast feedingSAFE IF PRESCRIBED
Administration of Kamika 250mg Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no appreciable risk to the infant.
DrivingUNSAFE
The injection Kamika 250mg can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Administering Kamika 250mg Injection requires careful consideration in individuals with impaired renal function. Dosage modification for Kamika 250mg Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Kamika 250mg Injection in individuals with hepatic impairment is likely safe. Current evidence indicates dose modification may be unnecessary, however, medical advice is recommended.
What if you forget to take Kamika 250mg Injection :
Should you forget a scheduled dose of Kamika 250mg Injection, seek medical advice.
Facts to Know About Kamika 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Behavioral Class | Aminoglycoside antibiotics |
